Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hummel

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Pediatrics|August 3, 2015
The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1Carlos E Prada, Robert B Hufnagel, Trent R Hummel, et al.
Journal of Pediatric Hematology/Oncology|June 11, 2020
Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK InhibitorMargot A Lazow, Sarah A Lawson, Ralph Salloum, et al.
The Biochemical Journal|September 1, 1994
Yeast acyl-CoA-binding protein: acyl-CoA-binding affinity and effect on intracellular acyl-CoA pool sizeJ Knudsen, N J Faergeman, H Skøtt, et al.
Journal of Dental Research|May 10, 2019
Caries Progression Rates Revisited: A Systematic ReviewR Hummel, N A E Akveld, J J M Bruers, et al.
Pediatric Blood & Cancer|November 9, 2018
Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2Laura Agresta, Ralph Salloum, Trent R Hummel, et al.
JACC. Cardiooncology|October 31, 2024
Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors: A Retrospective, Single-Center StudyJonathan D Bender, Natasha Pillay-Smiley, Garick D Hill, et al.
Journal of Neuro-Oncology|January 14, 2015
Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelaeDavid Gass, Mariko Dewire, Lionel Chow, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullinTrent R Hummel, Walter J Jessen, Shyra J Miller, et al.
Journal of Medicinal Chemistry|September 20, 2025
Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ)Ming Xiang, Shicheng Shi, Shaoqun Qian, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Pediatrics|August 3, 2015
The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1Carlos E Prada, Robert B Hufnagel, Trent R Hummel, et al.
Journal of Pediatric Hematology/Oncology|June 11, 2020
Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK InhibitorMargot A Lazow, Sarah A Lawson, Ralph Salloum, et al.
The Biochemical Journal|September 1, 1994
Yeast acyl-CoA-binding protein: acyl-CoA-binding affinity and effect on intracellular acyl-CoA pool sizeJ Knudsen, N J Faergeman, H Skøtt, et al.
Journal of Dental Research|May 10, 2019
Caries Progression Rates Revisited: A Systematic ReviewR Hummel, N A E Akveld, J J M Bruers, et al.
Pediatric Blood & Cancer|November 9, 2018
Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2Laura Agresta, Ralph Salloum, Trent R Hummel, et al.
JACC. Cardiooncology|October 31, 2024
Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors: A Retrospective, Single-Center StudyJonathan D Bender, Natasha Pillay-Smiley, Garick D Hill, et al.
Journal of Neuro-Oncology|January 14, 2015
Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelaeDavid Gass, Mariko Dewire, Lionel Chow, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullinTrent R Hummel, Walter J Jessen, Shyra J Miller, et al.
Journal of Medicinal Chemistry|September 20, 2025
Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ)Ming Xiang, Shicheng Shi, Shaoqun Qian, et al.
Pageof 11